skip to content
Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products. Preview this item
ClosePreview this item
Checking...

Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.

Author: Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)
Publisher: [Rockville, MD] : Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [1995]
Edition/Format:   eBook : Document : National government publication : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: Print version:
Guidance for industry
(OCoLC)34148352
Material Type: Document, Government publication, National government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)
OCLC Number: 496287106
Notes: "November 1995."
Description: 1 online resource (i, 16 pages)
Other Titles: Content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/496287106> # Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
    a schema:Book, schema:MediaObject, schema:CreativeWork ;
   library:oclcnum "496287106" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/mdu> ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/370223386#Place/rockville_md> ; # Rockville, MD
   schema:about <http://experiment.worldcat.org/entity/work/data/370223386#Topic/pharmaceutical_biotechnology_government_policy_united_states> ; # Pharmaceutical biotechnology--Government policy--United States
   schema:about <http://id.worldcat.org/fast/898943> ; # Drugs--Testing--Government policy
   schema:about <http://experiment.worldcat.org/entity/work/data/370223386#Topic/drugs_testing_government_policy_united_states> ; # Drugs--Testing--Government policy--United States
   schema:about <http://id.worldcat.org/fast/1204155> ; # United States
   schema:alternateName "Content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products" ;
   schema:bookFormat schema:EBook ;
   schema:contributor <http://viaf.org/viaf/125284200> ; # Center for Biologics Evaluation and Research (U.S.)
   schema:contributor <http://viaf.org/viaf/127540791> ; # Center for Drug Evaluation and Research (U.S.)
   schema:datePublished "1995" ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/370223386> ;
   schema:genre "National government publication"@en ;
   schema:genre "Government publication"@en ;
   schema:inLanguage "en" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/34148352> ;
   schema:name "Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products."@en ;
   schema:productID "496287106" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/496287106#PublicationEvent/rockville_md_center_for_drug_evaluation_and_research_center_for_biologics_evaluation_and_research_1995> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/370223386#Agent/center_for_drug_evaluation_and_research> ; # Center for Drug Evaluation and Research
   schema:publisher <http://experiment.worldcat.org/entity/work/data/370223386#Agent/center_for_biologics_evaluation_and_research> ; # Center for Biologics Evaluation and Research
   schema:url <http://purl.access.gpo.gov/GPO/LPS118486> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/496287106> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/370223386#Agent/center_for_biologics_evaluation_and_research> # Center for Biologics Evaluation and Research
    a bgn:Agent ;
   schema:name "Center for Biologics Evaluation and Research" ;
    .

<http://experiment.worldcat.org/entity/work/data/370223386#Agent/center_for_drug_evaluation_and_research> # Center for Drug Evaluation and Research
    a bgn:Agent ;
   schema:name "Center for Drug Evaluation and Research" ;
    .

<http://experiment.worldcat.org/entity/work/data/370223386#Topic/drugs_testing_government_policy_united_states> # Drugs--Testing--Government policy--United States
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh85039755> ;
   schema:name "Drugs--Testing--Government policy--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/370223386#Topic/pharmaceutical_biotechnology_government_policy_united_states> # Pharmaceutical biotechnology--Government policy--United States
    a schema:Intangible ;
   schema:hasPart <http://id.loc.gov/authorities/subjects/sh90004049> ;
   schema:name "Pharmaceutical biotechnology--Government policy--United States"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States
    a schema:Place ;
   schema:name "United States" ;
    .

<http://id.worldcat.org/fast/898943> # Drugs--Testing--Government policy
    a schema:Intangible ;
   schema:name "Drugs--Testing--Government policy"@en ;
    .

<http://viaf.org/viaf/125284200> # Center for Biologics Evaluation and Research (U.S.)
    a schema:Organization ;
   schema:name "Center for Biologics Evaluation and Research (U.S.)" ;
    .

<http://viaf.org/viaf/127540791> # Center for Drug Evaluation and Research (U.S.)
    a schema:Organization ;
   schema:name "Center for Drug Evaluation and Research (U.S.)" ;
    .

<http://www.worldcat.org/oclc/34148352>
    a schema:CreativeWork ;
   rdfs:label "Guidance for industry" ;
   schema:description "Print version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/496287106> ; # Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
    .

<http://www.worldcat.org/title/-/oclc/496287106>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
   schema:about <http://www.worldcat.org/oclc/496287106> ; # Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
   schema:dateModified "2017-12-25" ;
   void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.